Leaderboard

En | De
Sie sind hier: Hämatologie » Neoplasie 23. April 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Anämie
Gerinnungsstörungen
Neoplasie
Anderes
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8362  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 167231  
   
Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: A Randomized Clinical Trial.
JAMA
Xu PP, Song YQ, Shen JZ, Cai QQ, Zhou H, Zhang LL, Xiang Y, Sun XH, Yang W, Yao ZH, Jing HM, Wen SJ, Jin J, Xue HW, Cen H, Ding KY, Jin ZM, Liu LH, Xing XJ, Li LF, Hou M, Liu L, Zhang MZ, Li WY, Bai O, Feng R, Zhu ZM, Wu HJ, Su LP, Gao L, Li F, Huang WR, Liu P, Yan XJ, Zhao Y, Su H, Zhao XL, Fu R, Liu H, Shi WY, Li HZ, Chen B, Ning ZQ, Zhu J, Zhao WL.
PMID: 42018318 [PubMed - as supplied by publisher]


Rituximab, Acalabrutinib, and Durvalumab for Primary Central Nervous System Lymphoma: A Single-arm, Phase 1b, Multi-center Study.
Clin Cancer Res
Chang KY, Hsu YT, Chuang SS, Hsiao CF, Huang TC, Hsieh CY, Yeh SP, Ma WL, Wang MC, Chen TY, Hsueh PR, Wu SJ.
PMID: 42018298 [PubMed - as supplied by publisher]


Primary Cardiac Diffuse Large B-Cell Lymphoma: A Diagnostic Pitfall With Overlapping Imaging Features.
JACC Case Rep
Ünlügenç H, Y, Demir D, Bayraktaro, Demir E, Özerkan Çakan F, Nalbantgil S.
PMID: 42017852 [PubMed - as supplied by publisher]


Comment on: Clinical Characteristics and Prognostic Risk Factors for Pediatric B-Cell Lymphoblastic Lymphoma: A Multicenter Retrospective Cohort Study for China Net Childhood Lymphoma.
Pediatr Blood Cancer
Wu K, Zhou H.
PMID: 42017395 [PubMed - as supplied by publisher]


Cardiovascular Events and Management Strategies Including Tyrosine Kinase Inhibitor Switching, Dose Reduction, and Discontinuation in Chronic Myeloid Leukemia: A Single-Center Retrospective Study.
Cureus
Sato N, Yoshimaru R, Guo YM, Nakamura H, Chi S, Matsuda K, Minami Y, Yuda J.
PMID: 42017086 [PubMed]


Characterizing the distribution of Chinese medicine syndrome of cancer-related fatigue in childhood lymphoma based on latent structure model.
J Tradit Chin Med
Ziqi D, Jing H, Lu LU, Yuru C, Guoling G, Yanlong D, Ling J, Shuang H, Meng Z, Nan LI, Zhen G, Jiaxuan L.
PMID: 42015784 [PubMed - indexed for MEDLINE]


Clinicopathological factors associated with the prognosis and relapse of primary cutaneous marginal zone lymphoma: a retrospective cohort study.
Leuk Lymphoma
Moon IJ, Choi J, Jung JM, Won CH, Chang SE, Lee MW, Lee WJ.
PMID: 42015660 [PubMed - as supplied by publisher]


Phase I/II Trial of the FLT3 Kinase Inhibitor XY0206 in Patients With Relapsed/Refractory Acute Myeloid Leukemia.
Eur J Haematol
Song L, Wei X, Zhai Z, Wang A, Jiang D, Liang Y, Li F, Jiang Z, Zhang X, Guo Q, Jing H, Xu Y, Tong X, Wang J, Wang J, Qi J.
PMID: 42015516 [PubMed - as supplied by publisher]


Real-world efficacy of Bruton tyrosine kinase inhibitor based maintenance therapy in diffuse large B-cell lymphoma: a multicenter retrospective cohort study with external historical control.
Cancer Biol Ther
Lyu LW, Yao N, Liu ZX, Wang YY, Li J, Zhou HB, Li LH, Li ZL, Wang L.
PMID: 42015349 [PubMed - indexed for MEDLINE]


A diagnostic randomized controlled trial to validate novel dried blood spot (DBS) based technology for prognosis and screening of leukemia transcripts: study protocol.
Trials
Sharma S, Swain SK, Rishi B, Kaur M, Joseph GT, George NG, Kushwaha N, Dhanda H, Rajkamal, Surbhi, Chaudhry S, Sahoo D, Jain A, Singh A, Siraj F, Misra A.
PMID: 42015297 [PubMed - as supplied by publisher]


Clinical Characteristics and Prognostic Prediction of Secondary Solid Malignancies in Patients With Diffuse Large B-Cell Lymphoma and Follicular Lymphoma.
Cancer Med
Zhang L, Tian J, Xiong Q, Ye H, Wang Z, Wang Y, Guo C, Huang H.
PMID: 42014937 [PubMed - indexed for MEDLINE]


First-line Polatuzumab vedotin plus R-CHP in primary mediastinal B-cell lymphoma: A real-world study bridging the gap of the POLARIX trial.
Ann Hematol
Yang X, Ren Y, Cheng L, Liu Y, Yao J, Tan H, Liu P.
PMID: 42014623 [PubMed - in process]


Hypercalcaemia as the first clinical manifestation of follicular lymphoma.
BMJ Case Rep
Burrell LM, Brugliera IAR, Waters MF.
PMID: 42014162 [PubMed - indexed for MEDLINE]


Impact of peri-transplant consolidative radiotherapy in patients with relapsed or refractory classical Hodgkin lymphoma.
Leuk Lymphoma
Campbell BA, Minson A, Brown RJ, Chin CK, Wirth A, Hofman MS, MacManus M, Seymour JF, Ritchie D, Dickinson M.
PMID: 42012998 [PubMed - indexed for MEDLINE]


Web-Based Cognitive Rehabilitation for Patients With Aggressive Lymphoma With Perceived Cognitive Impairment: A Randomised Pilot Study.
Psychooncology
Gates P, Guarnera J, Gough K, Dhillon HM, Green HJ, Dickinson M, Vardy JL, Dryden T, Livingston PM, Duque JD, Caeyenberghs K.
PMID: 42012802 [PubMed - indexed for MEDLINE]


A systematic review and meta-analysis of shRNA-IL-6-engineered CAR-T cells for B-cell Acute Lymphoblastic Leukemia: a stepping stone towards risk-free immunotherapy.
Biosci Rep
Attia MS, Dyer B, McMillan N, Zunk M.
PMID: 42012511 [PubMed - as supplied by publisher]


Retrospective study of antimicrobial prophylaxis and infections in patients with acute myeloid leukemia.
J Oncol Pharm Pract
Jang J, Nold T, Marshalek JP, Matthiesen J, Tomassetti S.
PMID: 42012277 [PubMed - as supplied by publisher]


Importance of five membered heterocyclic compounds in treatment of chronic myeloid leukemia by targeting various pathways.
Future Med Chem
Ninave R, Mourya A, Prajapati N.
PMID: 42011924 [PubMed - as supplied by publisher]


Studies continue to individualize treatment strategies for patients with CLL and SLL: Trial data show that first-line pirtobrutinib significantly improves progression-free survival in patients with previously untreated chronic or small lymphocytic leukemia.
Cancer
Lawrence L.
PMID: 42011745 [PubMed - in process]


Impact of Dosing Interval Adherence on Pharmacokinetic Outcomes of Recombinant Erwinia Asparaginase in Pediatric Leukemia or Lymphoma.
Pharmacotherapy
Matherne MM, Panetta JC, Hopp J, Inaba H, Pui CH, Karol SE, Bernhardt MB, Swanson HD.
PMID: 42011546 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 167231    Seite 1 von 8362  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1